Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients
Retraction Based On Data Given To Duke Last November, But Apparently Disregarded
Grassley Seeks Data On Sponsored Travel By NCI Scientists
Letter to the Editor: IOM Study Welcome For “Omic” Research
Trending Stories
- Karen Knudsen to leave ACS
- A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease
- Factors outside CAR T-cell therapy are associated with increased risk of secondary cancers after the treatment, meta-analysis shows
Subgroup analysis suggests risk of secondary cancers after CAR T-cell therapy is similar to risk after other therapies - Jeffrey S. Weber, pioneering immunologist and melanoma expert at NYU, dies at 72
- Tumors are able to form with no DNA mutations, fly study shows
- From clinician scientist to nonprofit CEO